| Literature DB >> 25392671 |
Vishwajeet Singh1, Rahul Janak Sinha1, Dheeraj Kumar Gupta1, Vikas Kumar1, Mohit Pandey2, Asif Akhtar3.
Abstract
BACKGROUND AND OBJECTIVES: To compare laparoscopic transperitoneal versus retroperitoneoscopic pyeloplasty for primary ureteropelvic junction obstruction in a prospective randomized manner and assess overall results with long-term follow-up.Entities:
Keywords: Primary ureteropelvic junction obstruction; Pyeloplasty; Randomized; Retroperitoneal; Transperitoneal
Mesh:
Year: 2014 PMID: 25392671 PMCID: PMC4208907 DOI: 10.4293/JSLS.2014.00366
Source DB: PubMed Journal: JSLS ISSN: 1086-8089 Impact factor: 2.172
Comparison of Baseline Characteristics in TPLP and RPLP Groups
| Parameter | Group I (n = 56) | Group II (n = 56) | |
|---|---|---|---|
| Mean age (y) | 24.79 ± 3.96 | 24.93 ± 3.94 | .77 |
| Sex ratio (male/female) | 30:26 | 32:24 | .77 |
| Mean BMI[ | 25.44 ± 3.49 | 26.83 ± 3.91 | .15 |
| Laterality (right/left) | 26:30 | 25:31 | .78 |
| Mean serum creatinine level (mg/dl) | 1.41 ± 0.49 | 1.43 ± 0.47 | .58 |
| Mean preoperative split renal function (%) | 40.39 ± 2.92 | 41.96 ± 2.42 | .76 |
| ASA[ | |||
| 1 | 40 | 42 | .83 |
| 2 | 16 | 14 | .82 |
| Grade of hydronephrosis | |||
| II | 18 | 16 | .34 |
| III | 22 | 25 | .84 |
| IV | 16 | 15 | .83 |
| Associated caliceal stones | 4 of 56 | 6 of 56 | .49 |
| Anterior crossing vessels at UPJ | 21 of 56 | 23 of 56 | .59 |
ASA = American Society of Anesthesiologists; BMI = body mass index.
Comparison of Operative and Postoperative Results Between TPLP and RPLP Groups
| Parameter | Group I (n = 56) | Group II (n = 56) | |
|---|---|---|---|
| Mean total operating time (min) | 162.14 ± 18.13 | 188.21 ± 24.05 | .001 |
| Mean intracorporeal suturing time (min) | 67.07 ± 9.38 | 89.39 ± 6.78 | .001 |
| Mean VAS score on postoperative day 1 | 5.75 ± 0.65 | 5.29 ± 0.60 | .004 |
| Mean VAS score on postoperative day 2 | 2.57 ± 0.50 | 2.39 ± 0.50 | .10 |
| Mean tramadol dose on day 1 (mg) | 179.17 ± 32.69 | 147.92 ± 34.52 | .002 |
| Mean tramadol dose on day 2 (mg) | 93.75 ± 16.89 | 90.75 ± 24.72 | .07 |
| Mean hospital stay (d) | 3.39 ± 0.28 | 3.14 ± 0.36 | .036 |
| Mean follow-up (mo) | 30.75 ± 4.85 | 30.99 ± 5.59 | .88 |
| Mean postoperative split renal function at 3 mo (%) | 48.89 ± 7.48 | 48.78 ± 8.61 | .76 |
Postoperative Modified Clavien Complications in TPLP and RPLP Groups
| Complication | No. of Patients (%) | ||
|---|---|---|---|
| Group I (n = 56) | Group II (n = 56) | ||
| Clavien grade I | |||
| Transient mild hematuria | 1 (1.8) | — | >.99 |
| Subcutaneous emphysema | — | 1 (1.8) | >.99 |
| Clavien grade II | |||
| Temporary ileus | 6 (10.8) | — | .02 |
| Fever (UTI[ | 1 (1.8) | 1 (1.8) | >.99 |
| Prolonged urine drainage | — | 1 (1.8) | >.99 |
| Port-site infection | 1 (1.8) | — | >.99 |
| Clavien grade IIIb | |||
| Secondary UPJ obstruction | 2 (3.6) | 2 (3.6) | >.99 |
UTI = urinary tract infection.